CTBP2 and neoplasm: Thus, we hypothesized that declined miR-101 expression in human KLRG1+ T cells leaded to elevated expression of co-repressor CtBP2, which subsequently suppressed the effector cytokine production of KLRG1+ T cells, resulting in impaired T cell antitumor immunity in tumor microenvironment.